Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue

Litchfield, Kevin, Stanislaw, Stacey, Spain, Lavinia, Gallegos, Lisa L, Rowan, Andrew, Schnidrig, Desiree, Rosenbaum, Heidi, Harle, Alexandre, Au, Lewis, Hill, Samantha M
et al (show 22 more authors) (2020) Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue. CELL REPORTS, 31 (5). 107550-.

[thumbnail of PIIS2211124720304605.pdf] Text
PIIS2211124720304605.pdf - Published version

Download (3MB) | Preview


Although thousands of solid tumors have been sequenced to date, a fundamental under-sampling bias is inherent in current methodologies. This is caused by a tissue sample input of fixed dimensions (e.g., 6 mm biopsy), which becomes grossly under-powered as tumor volume scales. Here, we demonstrate representative sequencing (Rep-Seq) as a new method to achieve unbiased tumor tissue sampling. Rep-Seq uses fixed residual tumor material, which is homogenized and subjected to next-generation sequencing. Analysis of intratumor tumor mutation burden (TMB) variability shows a high level of misclassification using current single-biopsy methods, with 20% of lung and 52% of bladder tumors having at least one biopsy with high TMB but low clonal TMB overall. Misclassification rates by contrast are reduced to 2% (lung) and 4% (bladder) when a more representative sampling methodology is used. Rep-Seq offers an improved sampling protocol for tumor profiling, with significant potential for improved clinical utility and more accurate deconvolution of clonal structure.

Item Type: Article
Uncontrolled Keywords: PEACE Consortium, Humans, Lung Neoplasms, Biopsy, Tumor Burden, Mutation, Urinary Bladder Neoplasms, High-Throughput Nucleotide Sequencing, Biomarkers, Tumor
Depositing User: Symplectic Admin
Date Deposited: 21 May 2020 09:00
Last Modified: 18 Jan 2023 23:51
DOI: 10.1016/j.celrep.2020.107550
Related URLs: